Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
Genome Science Division, Research Center for Advanced Science and Technologies, The University of Tokyo, Meguro-ku, Tokyo 153-8904, Japan.
Sci Adv. 2023 Apr 14;9(15):eade7047. doi: 10.1126/sciadv.ade7047.
Mutations in the gene encoding Lamin A and C (Lamin A/C), major components of the nuclear lamina, cause laminopathies including dilated cardiomyopathy (DCM), but the underlying molecular mechanisms have not been fully elucidated. Here, by leveraging single-cell RNA sequencing (RNA-seq), assay for transposase-accessible chromatin using sequencing (ATAC-seq), protein array, and electron microscopy analysis, we show that insufficient structural maturation of cardiomyocytes owing to trapping of transcription factor TEA domain transcription factor 1 (TEAD1) by mutant Lamin A/C at the nuclear membrane underlies the pathogenesis of Q353Rrelated DCM. Inhibition of the Hippo pathway rescued the dysregulation of cardiac developmental genes by TEAD1 in mutant cardiomyocytes. Single-cell RNA-seq of cardiac tissues from patients with DCM with the mutation confirmed the dysregulated expression of TEAD1 target genes. Our results propose an intervention for transcriptional dysregulation as a potential treatment of -related DCM.
基因编码核纤层主要成分核纤层蛋白 A 和 C(Lamin A/C)的突变会导致核纤层病,包括扩张型心肌病(DCM),但潜在的分子机制尚未完全阐明。在这里,我们利用单细胞 RNA 测序(RNA-seq)、转座酶可及染色质测序(ATAC-seq)、蛋白质阵列和电子显微镜分析,表明由于突变型 Lamin A/C 在核膜上捕获转录因子 T 区结构域转录因子 1(TEAD1),导致心肌细胞结构成熟不足,这是 Q353R 相关 DCM 的发病机制。Hippo 通路的抑制作用挽救了突变型心肌细胞中 TEAD1 对心脏发育基因的失调调控。来自 DCM 突变患者心脏组织的单细胞 RNA-seq 证实了 TEAD1 靶基因的失调表达。我们的研究结果提出了一种针对转录失调的干预措施,作为治疗相关 DCM 的潜在方法。